Epstein Becker & Green

Yesterday, I shared with you this post re-capping Alishan Naqvee’s introduction to the topic of anti-corruption at our 2011 Annual Meeting.  To follow up on that, we’ll review Stuart Gerson’s (Epstein Becker & Green) comments during the session regarding the Foreign Corrupt Practices Act (FCPA) and its implications for those in the room.  

Stuart provided the attendees with both an article he and a colleague authored on the FCPA, and an overview that their healthcare group had developed.  Stuart said that as Alishan had mentioned, both the FCPA and the new UK Anti-Bribery law are extraterritorial – but not only are they applied overseas throughout the world, but they are also applied against non-US citizens, as long as the commerce that they’re supporting is in the stream of interstate commerce within the US.

So non-US citizens who have never stepped food in the US are subject to the FCPA, which is a criminal statute that has long jail sentences associated with it.  Additionally, they have fines up to $2 million per offense – and an offense is an individual act, so there could be a long series of them that results in the fines adding up to immense sums.  And this is applicable all around the world.Continue Reading Corporate Breakout Session – Anti-Corruption Laws – the FCPA

Welcome to ILN-terviews, a series of profiles of ILN member firm attorneys, designed to give a unique insight into the lawyers who make up our Network. For our latest interview, we chose ILN member, Stuart Gerson of Epstein Becker & Green, P.C. in Washington, D.C.

In one sentence, how would you describe your practice?
Representing